Interventional radiologists can deliver therapeutics directly to a tumor via needle injection. One of the major limitations of directly injected gene therapies is limited delivery, penetration, and transfection efficiency of the genetic vector, which in many cases directly limits the therapeutic effect. Several preclinical oncology models exist that rely on direct injection of DNA plasmid or vector through an end-hole needle and into a tumor. Selection of a physically more efficient device with more needles and more side holes could improve distribution of the therapeutic agent [1] . Small hepatocellular carcinomas have been effectively treated with alcohol injections via a multipronged, multiside hole needle [2] .
TNFerade (GenVec, Gaithersburg, MD) is an attenuated adenovirus vector whose cargo is the gene encoding for tumor necrosis factor alpha (TNFa), a potent cytokine that can be tumoricidal and also makes nearby tumor cells more sensitive to chemotherapy and radiotherapy. TNFerade is turned on by a promoter that is turned on by radiation [3] . TNFerade also causes a ''bystander effect'' whereby affected cells do not necessarily need to be transfected with virus but can respond to the TNFa product programmed by the gene. Despite the bystander effect, injectable therapeutics may suffer from lack of exposure to tumor tissue or a limited distribution in target tumor. Optimizing the physical distribution of such a therapeutic agent should be a goal of the interventional radiologist performing direct gene therapy injections.
Five patients with T3, T4, or N? rectal cancer were treated as part of a clinical trial with weekly transrectal ultrasound-guided injections, monitored under direct transrectal ultrasound visualization (Fig. 1) . Patients received injections via a Quadrafuse needle (Rex Medical, Conshohocken, PA, and Alliance Medical, Austin, TX) ( Fig. 1 ) with three prongs, each with three side holes, or a custom Bernardino needle (Cook Medical, Bloomington, IN) with three side holes. Five weekly injections of 4 9 10 10 particle units of TNFerade were combined with 50.4 Gy of external beam radiation, chemotherapy with capecitabine, and surgical resection. No complications were observed from the 25 injection procedures in five patients [3] .
Direct injection of gene therapy is highly inefficient, which may limit transfection and may theoretically limit the therapeutic efficacy. Interventional radiologists should consider the speculative benefits of multipronged and multi-side hole needles when directly injecting gene therapies. 
